Tivic Health Systems Inc

Investors weigh Tivic Health’s clinical promise against its stark losses—GAAP EPS –$1.97, $150k revenue, yet breakthrough nerve‑stimulation trials spark debate.

Tivic Health Systems, Inc. has made strategic moves to advance its microcurrent therapy solutions for chronic diseases, including a manufacturing agreement and new patent related to vagus nerve stimulation technology.